These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20202602)

  • 1. Neoadjuvant chemotherapy in MRI-staged rectal cancer.
    Glynne-Jones R
    Lancet Oncol; 2010 Mar; 11(3):213-4. PubMed ID: 20202602
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
    Glynne-Jones R; Meadows H; Wood W
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
    [No Abstract]   [Full Text] [Related]  

  • 3. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
    Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitizing drugs: lessons to be learned from the oxaliplatin story.
    Flatmark K; Ree AH
    J Clin Oncol; 2010 Oct; 28(29):e577-8; author reply e581-3. PubMed ID: 20733124
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
    Fakih MG
    Ann Oncol; 2006 Jun; 17(6):1029-30; author reply 1030-1. PubMed ID: 16384877
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.
    Sanghera P; Ho K; Muscroft T; Hartley A
    Br J Radiol; 2007 Aug; 80(956):e170-2. PubMed ID: 17762049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined-modality therapy for rectal cancer: future prospects.
    Czito BG; Willett CG; Bendell JC
    Clin Colorectal Cancer; 2007 Sep; 6(9):625-33. PubMed ID: 17945034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difference of colon cancer and rectal cancer-from the view of an oncological physician].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):321-3. PubMed ID: 20723426
    [No Abstract]   [Full Text] [Related]  

  • 9. Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?
    Glynne-Jones R; Sebag-Montefiore D
    J Clin Oncol; 2010 Oct; 28(29):e579-80; author reply e581-3. PubMed ID: 20733130
    [No Abstract]   [Full Text] [Related]  

  • 10. Neoadjuvant chemoradiation for rectal cancer: is more better?
    Patel A; Puthillath A; Yang G; Fakih MG
    Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current options for the management of rectal cancer.
    O'Neil BH; Tepper JE
    Curr Treat Options Oncol; 2007 Oct; 8(5):331-8. PubMed ID: 18181024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laparoscopic ovarian transposition and cryopreservation of ovarian tissue before chemo-radiotherapy for rectal cancer].
    Baron M; Resch B; Di Fiore F; Tenière P; Rives N
    Gynecol Obstet Fertil; 2007 Sep; 35(9):772-5. PubMed ID: 17693116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of neoadjuvant treatment in cT3N0M0 rectal cancer.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Rugge M; Sinigaglia G; Rossi E; Compostella A; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(6B):4129-35. PubMed ID: 19192672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
    Chua YJ; Barbachano Y; Cunningham D; Oates JR; Brown G; Wotherspoon A; Tait D; Massey A; Tebbutt NC; Chau I
    Lancet Oncol; 2010 Mar; 11(3):241-8. PubMed ID: 20106720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy and rectal cancer].
    Michel P; Di Fiore F
    Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.
    Wong SJ; Moughan J; Meropol NJ; Anne PR; Kachnic LA; Rashid A; Watson JC; Mitchell EP; Pollock J; Lee RJ; Haddock M; Erickson BA; Willett CG
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):116-23. PubMed ID: 25446610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality treatment for rectal cancer.
    Zhu AX; Willett CG
    Semin Oncol; 2005 Feb; 32(1):103-12. PubMed ID: 15726512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.